Acorda Therapeutics reported $5.97M in Cost of Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Acadia Pharmaceuticals ACAD:US $ 2.95M 0.39M
Acorda Therapeutics ACOR:US $ 5.97M 1.77M
Amgen AMGN:US $ 1561M 157M
Anika Therapeutics ANIK:US $ 14.89M 2.8M
Biogen BIIB:US $ 753.9M 93.8M
Biomarin Pharmaceutical BMRN:US $ 116.96M 2.78M
Clovis Oncology CLVS:US $ 9.41M 0.32M
Gilead Sciences GILD:US $ 1424M 1203M
GlaxoSmithKline GSK:LN 3645M 30M
Halozyme Therapeutics HALO:US $ 15.92M 5.66M
Heron Therapeutics HRTX:US $ 11.36M 0.41M
Insmed INSM:US $ 12.19M 1.1M
Ligand Pharmaceuticals LGND:US $ 4.7M 7.28M
Mannkind MNKD:US $ 11M 0.44M
Merck MRK:GR € 1987M 28M
Moderna Inc MRNA:US 1.02B 65M
Novartis NOVN:VX SF 3755M 245M
Teva Pharmaceutical TEVA:IT 1.86B 116M
Ultragenyx Pharmaceutical RARE:US $ 6.1M 2.59M
Vertex Pharmaceuticals VRTX:US $ 245.8M 1.59M